Comparative bactericidal activity of ceftazidime against isolates of Pseudomonas aeruginosa as assessed in an in vitro pharmacodynamic model versus the traditional time-kill method

被引:10
|
作者
Manduru, M
Mihm, LB
White, RL
Friedrich, LV
Flume, PA
Bosso, JA
机构
[1] MED UNIV S CAROLINA,COLL PHARM,QF 218,ANTIINFECT RES LAB,CHARLESTON,SC 29425
[2] MED UNIV S CAROLINA,COLL MED,DEPT MED,CHARLESTON,SC 29425
[3] MED UNIV S CAROLINA,COLL MED,DEPT PEDIAT,CHARLESTON,SC 29425
关键词
D O I
10.1128/AAC.41.11.2527
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Bactericidal activity, historically assessed by in vitro tests which employ fixed drug concentrations, may also be evaluated in in vitro pharmacodynamic models in which in vivo pharmacokinetics and bacterial growth conditions can be simulated, However, systematic comparisons between the two methods are lacking, We evaluated the bactericidal activities of ceftazidime, at two different concentration/MIC ratios (C/MICs), against 10 clinical isolates of Pseudomonas aeruginosa in a two-compartment model with continuous-infusion conditions and a 2-h half-life. These values were compared to those determined by traditional 24-h time-kill (TTK) methods at the same C/MICs, Bactericidal activities were compared by using area under the colony count-time curves, Antibiotic exposure (area under the drug concentration-time curve) was also evaluated, Although bactericidal activity appeared greater by the TTK method (P = 0.05), when it was normalized for drug exposure, these differences disappeared (P = 0.2), This disparity was likely due to differences in drug exposure in the TTK method and in the peripheral compartment of the model (site of bacteria) over the first 8 h of the experiment, during which the antibiotic accumulated to target concentrations, This suggests that the bactericidal effects with constant antibiotic concentrations are similar in the two methods; however, this may not hold true with fluctuating drug concentrations, Further, results from the pharmacodynamic model may theoretically be more relevant, as in vivo pharmacokinetics and bacterial growth conditions can be more faithfully simulated.
引用
收藏
页码:2527 / 2532
页数:6
相关论文
共 50 条
  • [1] Development of a rapid colorimetric time-kill assay for determining the in vitro activity of ceftazidime and tobramycin in combination against Pseudomonas aeruginosa
    Moriarty, F
    Elborn, S
    Tunney, M
    JOURNAL OF MICROBIOLOGICAL METHODS, 2005, 61 (02) : 171 - 179
  • [2] A mathematical model-based analysis of the time-kill kinetics of ceftazidime/avibactam against Pseudomonas aeruginosa
    Sy, Sherwin K. B.
    Zhuang, Luning
    Xia, Huiming
    Beaudoin, Marie-Eve
    Schuck, Virna J.
    Nichols, Wright W.
    Derendorf, Hartmut
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (05) : 1295 - 1304
  • [3] Bactericidal Activity, Absence of Serum Effect, and Time-Kill Kinetics of Ceftazidime-Avibactam against β-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa
    Keepers, Tiffany R.
    Gomez, Marcela
    Celeri, Chris
    Nichols, Wright W.
    Krause, Kevin M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (09) : 5297 - 5305
  • [4] Antimicrobial Activity of Fosfomycin-Tobramycin Combination against Pseudomonas aeruginosa Isolates Assessed by Time-Kill Assays and Mutant Prevention Concentrations
    Diez-Aguilar, Maria
    Isabel Morosini, Maria
    Tedim, Ana P.
    Rodriguez, Irene
    Aktas, Zerrin
    Canton, Rafael
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (10) : 6039 - 6045
  • [5] Is there a pharmacodynamic need for the use of continuous versus intermittent infusion with ceftazidime against Pseudomonas aeruginosa?: An in vitro pharmacodynamic model
    Alou, L
    Aguilar, L
    Sevillano, D
    Giménez, MJ
    Echeverría, O
    Gómez-Lus, ML
    Prieto, J
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (02) : 209 - 213
  • [6] Semimechanistic Pharmacokinetic-Pharmacodynamic Model with Adaptation Development for Time-Kill Experiments of Ciprofloxacin against Pseudomonas aeruginosa
    Gregoire, Nicolas
    Raherison, Sophie
    Grignon, Claire
    Comets, Emmanuelle
    Marliat, Manuella
    Ploy, Marie-Cecile
    Couet, William
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (06) : 2379 - 2384
  • [7] Antibacterial activity of liposomal gentamicin against Pseudomonas aeruginosa:: a time-kill study
    Rukholm, G
    Mugabe, C
    Azghani, AO
    Omri, A
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2006, 27 (03) : 247 - 252
  • [8] Synergistic activity of colistin and ceftazidime against multiantibiotic-resistant Pseudomonas aeruginosa in an in vitro pharmacodynamic model
    Gunderson, BW
    Ibrahim, KH
    Hovde, LB
    Fromm, TL
    Reed, MD
    Rotschafer, JC
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (03) : 905 - 909
  • [9] Comparative Activity of Ciprofloxacin, Levofloxacin and Moxifloxacin against Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia Assessed by Minimum Inhibitory Concentrations and Time-Kill Studies
    Grillon, Antoine
    Schramm, Frederic
    Kleinberg, Magali
    Jehl, Francois
    PLOS ONE, 2016, 11 (06):
  • [10] Activity of piperacillin/tazobactam in combination with amikacin, ciprofloxacin, and trovafloxacin against Pseudomonas aeruginosa by time-kill
    Burgess, DS
    Hastings, RW
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 38 (01) : 37 - 41